NCT04530071View on ClinicalTrials.gov

Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

April 17, 2023

Study Completion Date

April 17, 2023

Conditions
Chronic Low-back PainDisc Degeneration
Interventions
BIOLOGICAL

CordSTEM-DD (0.7 x 10^7 cells)

CordSTEM-DD (0.7 x 10\^7 cells)

BIOLOGICAL

CordSTEM-DD (2.1 x 10^7 cells)

CordSTEM-DD (2.1 x 10\^7 cells)

BIOLOGICAL

Placebo

HA + saline + placebo comparator

Trial Locations (1)

Unknown

CHA Bundand Medical Center, Seongnam-si

All Listed Sponsors
collaborator

Seoul CRO Co., Ltd.

UNKNOWN

lead

CHABiotech CO., Ltd

INDUSTRY

NCT04530071 - Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain | Biotech Hunter | Biotech Hunter